Kollagen, ein Biomaterial in der Medizin

LITERATUR
1 Adamson The effect of collagen on cell division, cellular differentiation and embryonic development. In: Collagen in Health and Disease. Weiss BJ, Jayson MIV. (eds). Edinburgh: Churchill Livingstone; 1982: 218-43.
2 Adelmann BC, Gentner GJ. Dependence of the antibody response of guinea-pigs to collagen on the type of adjuvant and on the conformation of the antigen. Z Immun Forsch 1977; 152: 369-80.
3 Akrami R, Kalmar P, Pokar H, Tilsner V. Abdichtung von Kunststoffprothesen beim Ersatz der Aorta im thorakalen Bereich. Thoraxchirurgie 1978; 26: 144-47.
4 Allgöwer M. Weichteilprobleme und Infektionsrisiko der Osteosynthese. Langenbecks Arch Chir 1971; 329: 1127-36.
5 Amon H, Kirschbaum M, Petry G. Licht-und elektronenmikroskopische Untersuchung über die lokalen Reaktionen auf implantiertes Kollagen-Hämostyptikum. Eine tierexperimentelle Studie. Langenbecks Arch Chir 1984; 362: 167-83.
6 Armstrong RB, Nichols J, Pachance J. Punch biopsy wounds treated with Monsel’s solution or a collagen matrix. Arch Dermatol 1986; 122: 546-49.
7 Asyee G, Sturk A, Kappelmayer J, Muszbek L. Platelet vinculin, a substrate for activated factor XIII. Thromb Haemost 1985; 54: 63.
8 Bale MD, Mosher DF. Thrombospondin is a substrate for factor XIIIa. Thromb Haemost 1985; 54: 2 (Abstr)
9 Bale MD, Mosher DF. Copolimerization of thrombospondin and fibrin. Thromb Haemost 1985; 54: 2 (Abstr)
10 Balleisen L, Marx R, Kühn K. Über die stimulierende Wirkung von Kollagen und Kollagenderivaten auf die Ausbreitung und Folienadhäsion von Thrombozyten in defibrinogenisiertem Menschenzitratplasma und in tierischen Zitratplasmen. Blut 1975; 31: 95-106.
11 Barnes MJ. The collagen-platelet interaction. In: Collagen in Health and Disease. Weiss JB, Jayson MIV. (eds). Edinburgh: Churchill Livingstone; 1982: 179-97.
12 Barrows TH. Degradable implant materials: a review of synthetic absorbable polymers and their applications. Clin Mat 1986; 01: 233-57.
13 Barza M, Brown R, Shen D, Gibaldi I, Weinstein L. Predictability of blood levels in man. J Infect Dis 1975; 132: 165-74.
14 Bascom JV. Gelatin sealing to prevent blood loss from knitted arterial grafts. Surgery 1961; 50: 504-12.
15 Battista A. The reaction of various tissues to implants of a collagen derivate. Canad J Res 1949; 27: 94-104.
16 Beachey EH, Simpson WA. The adherence of group A streptococci to oropharyngeal cells: the lipoteichoic acid adhesin and fibronectin receptor. Infection 1982; 10: 107-11.
17 Becker U, Heimburger N. Untersuchungen zur Plättchenaggregation, Plättchenadhäsion und Wechselwirkung mit Gerinnungsfaktoren mit einem Human-TestKollagen. In: Fibrinogen, Fibrin und Fibrinkleber. Schimpf Kl. (Hrsg) Stuttgart, New York: Schattauer; 1979: 499-507.
18 Bedacht R. Kollagenanwendung bei posttraumatischer, chronisch rezidivierender Osteomyelitis. In: Die posttraumatische Osteomyelitis. Hierholzer G, Rehn J. (Hrsg). Stuttgart, New York: Schattauer; 1970: 163-69.
19 Bell E, Ivarsson B, Merrill Ch. Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc Natl Acad Sci 1979; 76: 1274-78.
20 Bell E, Sher S, Hull B, Merrill Ch, Rosen S, Chamson A, Asselineau D, Dubertret L, Coulomb B, Lapiere Ch, Nusgens B, Neveux Y. The reconstitution of living skin. J Invest Dermatol 1983; 81: 2s-10s.
21 Benfer J, Struck H. Förderung der Frakturheilung durch lokale Kollagenapplikation. Dtsch Med Wschr 1972; 97: 523-25.
22 Benslimane S, Guidoin R, Roy PE, Friede J, Hebert J, Domurado D, Sigot-Luizard MF. Degradability of crosslinked albumin as an arterial polyester prosthesis coating in in vitro and in vivo rat studies. Biomaterials 1986; 07: 268-72.
23 Bessho K, Tagawa T, Murata M. Purification of bone morphogenetic protein derivated from bovine bone matrix. Biochem Biophys Res Commun 1989; 165: 595-601.
24 Bethea MC, Reemtsma K. Graft hemostasis: An alternative to preclotting. Ann Thorac Surg 1979; 27: 374.
25 Blaine G. The uses of plastics in surgery. Lancet 1946; 10: 525-28.
26 Blaser J, Stone BB, Groner MC, Zinner StH. Comparative study with Enoxacin and Netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance. Antimicrob Agens Chemother 1987; 31: 1054-60.
27 Blombäck B, Blombäck M, Finkbeiner W, Holmgren A, Kowalska-Loth B, Olovson G. Enzymatic reduction of disulfide bonds in fibrinogen by the Thioredoxin system. I. Identification of reduced bonds and studies on reoxidation process. Thromb Res 1974; 04: 55-75.
28 Bogue RH. The Chemistry and Technology of Gelatin and Glue. New York: McGraw-Hill; 1922
29 Born GVR. Quantitative investigations into the aggregation of blood platelets. J Physiol Lond 1962; 162: 67-68.
30 Bornstein P, Majack RA. A role for thrombospondin in the vessel wall. Thromb Haemost 1985; 54: 117 (Abstr)
31 Bradley WG, Wilkes GL. Some mechanical property considerations or reconstituted collagen for drug release supports. Biomat Med Dev Art Org 1977; 05: 159-75.
32 Brändstedt S, Frank F, Olson PS. The fibrin net formed in a wound appears to act as a scaffold for migrating fibroblasts. Eur Surg Res 1980; 12: 18-21.
33 Bruck StD. Evaluation of blood compatibility of polymeric implants. In: Controlled Drug Delivery. VolII: Clinical Applications. Bruck StD. (ed). Boca-Raton/Flo-rida: CRC-Press; 1983: 47-62.
34 Bruck StD. Controlled Drug Delivery. Voll: Basic Concepts. Boca-Raton/Florida: CRC Press; 1983
35 Buchholz HW, Elson RA, Heinert K. Antibiotic-loaded acrylic cement: current concepts. Clin Orthop Rel Res 1984; 190: 96-108.
36 Buchholz HW, Engelbrecht H. Über die Depotwirkung einiger Antibiotika bei Vermischung mit dem Kunstharz Palacos. Chirurg 1970; 40: 511-16.
37 Burke JF, Yannas IV, Quinby WC, Bondoc CC, Jung WK. Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury. Ann Surg 1981; 10: 413-27.
38 Burri C. Posttraumatische Osteitis. In: Aktuelle Probleme der Chirurgie, Bd. 18. Bern, Stuttgart, Wien: Huber; 1974
39 Burri C. Grundlagen zur Taurolin-Gel-Anwendung in der Osteitisbehandlung. In: Taurolin. Brückner WL, Pfirrmann RW. (eds). München: Urban & Schwarzenberg; 1985: 133-35.
40 Burri C, Lob G. Taurolin-Gel in der Osteitis-Behandlung. Akt Traumatol 1982; 12: 159-65.
41 Chambard M, Gabrion J, Mauchamp J. Influence of collagen gel on the orientation of epithelial cell polarity: follicle formation from isolated thyroid cells and from preformed monolayers. J Cell Biol 1981; 91: 157-66.
42 Cheah KSE, Grant ME. Procollagen genes and messenger RNAs. In: Collagen in Health and Disease. Weiss JB, Jayson MIV. (eds). Edinburgh: Churchill Livingstone; 1982: 73-100.
43 Chiang TM, Postlethwaite AE, Beachey EH. Binding of chemotactic collagen-derived peptides to fibroblasts. The relationship to fibroblast chemotaxis. J Clin Invest 1978; 62: 916-22
44 Chvapil M. Collagen sponge: theory and practice of medical applications. J Biomed Mater Res 1977; 11: 721-41.
45 Chvapil M. Industrial uses of collagen. In: Fibrous Proteins, Scientific Industrial and Medical Aspects, Vol 1. Parry DAÖ, Craemer LK. (eds). New York: Academic Press; 1979: 247-69.
46 Chvapil M. Collagen in cosmetics: misconception of its mode of action. Cosmetics Toiletries 1982; 97: 35-36.
47 Chvapil M, Holusa R, Klimat K, Stoll M. Some chemical and biological characteristics of a new collagen-polymer compound material. J Biol Med Mater Res 1969; 03: 315-32.
48 Chvapil M, Krajicek M. Use of collagen in the construction of an arterial prosthesis. Med Trends Vase Surg 1970; 01: 120-40.
49 Chvapil M, Kronenthal Rl, van Winkle Jr W. Medical and surgical applications of collagen. In: International Review of Connective Tissue Research. Vol 6. Hall N, Jackson N. (eds). New York: Academic Press; 1973: 1-55.
50 Cohen I, Lim CT, Kahn DR. Disulfidelinked and transglutaminase-catalyzed protein assemblies in platelets. Thromb Haemost 1985; 54: 131 (Abstr)
51 Colago V, Hollenberg Ch, Penn I, Ross H, Zingg W, Ferguson C. An evaluation of the effect of powered collagen on the healing of experimental bone defects. Can J Surg 1965; 08: 412-17.
52 Coin D, Horton J, Ogden ME, Buja LM. Evaluation of hemostatic agents in experimental lacerations. Am J Surg 1983; 145: 256-59.
53 Cool DE, Edgell JS, MacGillivray RTA. Characterization of human factor XII cDNA. Thromb Haemost 1985; 54: 120 (Abstr)
54 Cooley DA, Romagnoli A. A method preparing woven dacron aortic grafts to prevent interstitial bleeding. Cardiovasc Dis Bull Tex Heart Inst 1981; 08: 48-54.
55 Coulomb B, Dubertet L, Merrill Ch, Touraine R, Bell E. The collagen lattice: a model for studying the physiology, biosynthetic function and pharmacology of the skin. Br J Dermatol 1984; 111 (Suppl27): 83-87.
56 De Lustro F, Condell R, Nguyen M, McPherson J. A comparative study of the biologic and immunologic response to medical devices derived from dermal collagen. J Biomed Mat Res 1986; 20: 109-20.
57 Delvos U, Preissner KT, Müller-Berghaus G. Cultured bovine endothelial cells bind soluble fibrin. Thromb Haemost 1985; 54: 5 (Abstr)
58 Eloy R, Baguet J, Christé G, Rissoan MC, Paul J, Belleville J. An in vitro evaluation of the hemostatic activity of topical agents. J Bio Mat Res 1988; 22: 149-57.
59 Eyre DR, Paz MA, Callop PM. Crosslinking in collagen and elastin. Ann Rev Biochem 1984; 53: 717-48.
60 Federspil P. Prophylaxe der Ototoxizität von Aminoglykosid-Antibiotika. Arzneimitteltherapie 1983; 01: 187-94.
61 Federspil P. Ototoxizität der neuen Aminoglykosid-Antibiotika unter besonderer Berücksichtigung des Netilmicins. In: Aminoglykoside in der Behandlung schwerer Infektionen. Linzenmeier G. (Hrsg). Erlangen: perimed; 1981: 49-56.
62 Fegerl H, Marek A. Verwendung von Nebacetin im Fibrinfilm. Gynaec 1955; 139: 190-94.
63 Feriz H. Experiments with tampons and membranes of collagen. Surgery 1940; 08: 654-61.
64 Fitzsimmons CM, Cockburn CG, Hornsey V, Prowse CV, Barnes MJ. The interaction of von Willebrand Factor (vWf) with collagen: investigation of vWf-binding sites in the collagen molecule. Thromb Haemost 1988; 59: 186-92.
65 Folk JE. Transglutaminases. Ann Rev Biochem 1980; 49: 517-31.
66 Fritsche HM, Jakob H, Spilker G, Stemberger A, Wriedt-Liibbe I, Haas S, Bliimel G. Tierexperimentelle Studie zur Versiegelung blutender Leberparenchymdefekte mittels Fibrinkleber und resorbierbaren Wundauflagen. In: Experimentelle und Klinische Hepatologie. Zelder O, Fischer M, Eckert P, Bode JC. (Hrsg). Stuttgart, New York: Thieme; 1980: 29-35.
67 Furthmayr H. Immunochemistry of the Extracellular Matrix. Voll: Methods. Vol II: Applications. Boca-Raton/Florida: CRC-Press; 1982: 143-75.
68 Galanakis DK, Lane BP. Evidence that albumin limits diameter growth during fibrin assembly. Thromb Haemost 1985; 54: 161 (Abstr)
69 Galvin NJ, Dixit VM, Rourke KO, Santoro SA, Grant GA, Frazier WA. Mapping of epitopes for monoclonal antibodies against human platelet thrombospondin with electronmicroscopy and high sensitivity amino acid sequencing. J Cell Biol 1985; 101: 1434-41.
70 Ganns HJ. Resorbierbare Tamponmaterialien. Arzneimittelforschung 1953; 03: 379-86.
71 Gay S, Miller EJ. Collagen in the physiology and pathology of connective tissue. In: Collagen. Gay S, Miller EJ. (eds). Stuttgart, New York: Fischer; 1978
72 Grinell F, Minter D. Attachment and spreading of baby hamster kidney cells to collagen substrate: Effects of cold-insoluble globulin. Proc Natl Acad Sci USA 1978; 75: 4408-12.
73 Guidoin R, King M, Marceau D, Cardou A, Faye D, Legendre JM, Blais P. Textile arterial prostheses: Is water permeability equivalent to porosity?. J Bio Mat Res 1987; 21: 65-87.
74 Hada M, Ikematsu S, Fujimaki M, Fukutake K, Kaminski M, McDonagh J. Crosslinking of von Willebrand factor to fibrin by factor XHIa. Thromb Haemost 1985; 54: 148 (Abstr)
75 Hager T. For the future: polymer drug systems (news). J Am Med Assoc 1983; 250: 145-47.
76 Hakomori S, Fukuda M, Sekiguchi K, Carter WG. Fibronectin, laminin and other extracellular glycoproteins. In: Extracellular Matrix Biochemistry. Piez KA, Reddi AH. (eds). Amsterdam: Elsevier North Holland; 1984: 229-55.
77 Haverich A, Walterbusch G, Borst HG. The use of fibrin glue for sealing vascular protheses of high porosity. Thorac Cardiovasc Surg 1981; 29: 252-54.
78 Heine WD, Braun A, Edinger D. Gewebliche Abwehrreaktionen auf das Fibrinklebesystem. In: Fibrinkleber in Orthopädie und Traumatologie. Cotta H, Braun A. (Hrsg). Stuttgart, New York: Thieme; 1982: 277-82.
79 Hewitt W. Gentamicin: toxicity in perspective. Postgrad Med J 1974; 50 (SupplA): 55-59.
80 Hörmann H. Biochemie und Physiologie der Kollagentypen. Hämostaseologie 1990; 10: 138-45.
81 Hörmann H, Stemberger A. Influence of Collagen on fibrin cross-linking. In: Collagen-Platelet-Interaction. Gastpar H, Kühn K, Marx R. (eds). Stuttgart, New York: Schattauer; 1978: 397-99.
82 Hukins DWL. Biomechanical properties of collagen. In: Collagen in Health and Disease. Weiss JB, Jayson MIV. (eds). Edinburgh: Churchill Livingstone; 1982: 49-72.
83 Humboldt Av. Südamerikanische Reise. Berlin: Safari-Verlag im Ullstein Verlag; 1976: 428.
84 Humphries AW, Hawk WA, Cuthbertson AM. Arterial prosthesis of collagen impregnated Dacron tulle. Surgery 1961; 50: 947-54.
85 Imura J, Ashihara Y, Nijimo H, Hoshikawa N, Shirasawa K. Correlative studies on the vascular permeability and growth factors of human platelets. Thromb Haemost 1985; 54: 70 (Abstr)
86 Jaffe R, Deykin D. Evidence for a structural requirement for the aggregation of platelets by collagen. J Clin Invest 1974; 53: 875-83.
87 Jeger E, Wohlgemut J. Eine neue Methode zur Stillung parenchymatöser Blutungen. Verhandl dtsch Gesellsch Chir II 1914; 43: 728-48.
88 Jezek M, Leikep K. Collagen foams as a biological burn dressing. Basic Problems in Burns 1974; 48-49.
89 Jonas RA, Ziemer G, Schoen FJ, Britton L, Castaneda AR. A new sealant for knitted Dacron prostheses: Minimally cross-linked gelatin. J Vase Surg 1988; 07: 414-19.
90 Jordan GL, Stump MM, Allen J, DeBakey ME, Halpert B. Gelatin impregnated Dacron prosthesis implanted in porcine thoracic aorta. Surgery 1963; 53: 45-49.
91 Kaufmann G. Handbuch der Unfallmedizin. Stuttgart: Enke; 1925
92 Kinel FA, Ciaccio L, Henderson StB. Collagen as a drug carrier. Arch Pharm 1984; 317: 657-61
93 Kivirikko KI, Myllylä R. Biosynthesis of the collagens. In: Extracellular Matrix Biochemistry. Piez KA, Reddi AH. (eds). Amsterdam: Elsevier North Holland; 1984: 83-112.
94 Klein AW, Rish DC. Injectable collagen update. J Dermatol Surg Oncol 1984; 10: 519-22.
95 Kleinmann HK. Interactions between connective tissue matrix macromolecules. Conn Tissue Res 1982; 10: 61-72.
96 Kleinmann HK, Klebe RJ, Martin GR. Role of collagenous matrices in the adhesion and growth of cells. J Cell Biol 1981; 88: 473-85.
97 Kleinmann HK, Rohrbach DH, Terranova VP, Varner HH, Hewitt AT, Grotendorst GR, Wilkes CM, Martin GR, Seppä H, Schiffmann E. Collagenous matrices as determinants of cell function. In: Immunochemistry of the Extracellular Matrix, Vol II. Furthmayr H. (ed). Boca-Raton/Florida: CRC-Press; 1982: 151-70.
98 Kna TR, Luck E, Daniels JR. Behavior of solubilized collagen as a bioimplant. J Surg Res 1977; 23: 96-105.
99 Ksander GA, Gray LBA. Reduced capsule formation around soft silicone rubber prostheses coated with solid collagen. Ann Plast Surg 1985; 14: 351-58.
100 Kühn K. Chemical properties of collagen. In: Immunochemistry of the Extracellular Matrix. Furthmayr H. (ed). Boca-Raton/ Florida: CRC-Press; 1982: 2-22.
101 Küster HH. Vergleichende Untersuchungen des Knochenregenerationsverhaltens nach Implantation von Kollagenbzw. Fibrinspongiosaplomben in standardisierte Bohrlochdefekte am Kaninchen. Z Orthop 1982; 120: 444.
102 Labow TA, Silvers DN. Late reactions at zyderm skin test sites. Cutis 1985; 35: 154-57.
103 Lambert CJ. Cardiopulmonary bypass hemorrhage: a surgeon’s point of view. Sem Thromb Hemost 1976; 03: 90-97.
104 Landsteiner K. The Specificity of Serological Reactions. London: Bailliere Tindall; 1936: 28.
105 Lawler J, Derick LH, Connolly JE, Chen JH, Chao FC. The structure of human platelet thrombospondin. J Biol Chem 1985; 260: 3762-72.
106 Leger D, Karniguian A, Soria J, Soria C, Legrand Y. Inhibition of some activities of thrombin by a collagen-derived octapeptide. Haemostasis 1985; 15: 293-99.
107 Lindenmaier HL, Wenig K, Köhnlein HE. Neue Anwendungsmöglichkeiten von Gelatine-Gewebeklebstoff an parenchymatösen Organen. Med Welt 1976; 27: 856-59.
108 Linsenmayer TF. Immunology of purified collagens and their use in localization of collagen types in tissues. In: Collagen in Health and Disease. Weiss JB, Jayson MIV. (eds). Edinburgh: Churchill Livingstone; 1982: 244-69.
109 Lister J. On the antiseptic principle in the practice of surgery. Br Med J 1867; 02: 246-48.
110 Lob G. Chronische posttraumatische Osteitis. Hefte zur Unfallheilkunde 1980; 145.
111 Lockwood W, Bower J. Tobramycin and Gentamicin concentrations in the serum of normal and anephric patients. Antimicrob Agents Chemother 1973; 13: 125-29.
112 Luft F, Kleit S. Renal parenchymal accumulation of aminoglykoside antibiotics in rats. J Infect Dis 1974; 130: 656-59.
113 Luft F, Yum M, Kleit S. Comparative nephrotoxicities of Netilmicin and Gentamicin in rats. Antimicrob Agents Chemother 1976; 10: 845-49.
114 Mallinger R, Meissl G, Reich ME. Collagen fascia as wound dressing in burns. Bull Clin Rev Burn Injuries 1985; II: 12-15.
115 Marion K, Gordon D, Gerecke R, Dublet B, Rest VdM, Sugrue SP, Olsen BR. The structure of type XII collagen. Ann NY Acad Sci 1990; 580: 8-16.
116 Marois Y, Boyer D, Guidoin R, Douville Y, Marois M, Tejieira FJ, Roy PE. In vivo evaluation of four chemically processed biological grafts implanted as infrarenal arterial substitutes in dogs. Biomaterials 1989; 10: 369-79.
117 Masilamani D, Salerno HR, Bhattacharjee Goldberg I, Unger PD, Oleksiuk M. Synthetic mussel adhesive proteins. Poly Mat Sci Eng 1990; 62: 568-70.
118 Martin GR, Timpf R, Müller PK, Kühn K. The genetically distinct collagens. TIBS 1985; 285-87.
119 Masilamani D, Salerno HR, Bhattacharjee Goldberg I, Unger PD, Oleksiuk M. Synthetic mussel adhesive proteins. Poly Mat Sci Eng 1990; 62: 568-70.
120 McPherson J, Ledger P, Sawamura S, Conti A, Wade A, Reihanian H, Wallace D. The preparation and physicochemical characterization of an injectable form of reconstituted, glutaraldehyde cross-linked bovine corium collagen. J Bio Mat Res 1986; 20: 79-92.
121 McPherson J, Sawamura S, Armstrong R. An examination of the biologic response to injectable, glutaraldehyde cross-linked collagen implants. J Bio Mat Res 1986; 20: 93-107.
122 Meier St, Hay ED. Control of corneal differentiation by extracellular materials. Collagen as a promoter and stabilizer of epithelial stroma production. Dev Biol 1974; 38: 249-70.
123 Mercier C, Bernard PJ, Piligian F, Piquet P. Collagen-impregnated grafts and platelet adhesion. Angio Archiv 1985; 09: 44-48.
124 Metha J, Wargovich T, Nichols WW, Saldeen K, Wallin R, Saldeen T. Fibrin-(ogen)-derived vasoactive peptides increase coronary blood flow in the anesthetized dog. Thromb Haemost 1985; 54: 58 (Abstr)
125 Miller EJ. Chemistry of the collagens and their distribution. In: Extracellular Matrix Biochemistry. Piez KA, Reddi AH. (eds). Amsterdam: Elsevier North Holland; 1984: 41-82.
126 Mlczoch F, Vinazzer H. Ein Apparat zur Herstellung eines antibiotischen Fibrinfilms. Wien Klin Wschr 1952; 64: 457-58.
127 Moore WS, Chvapil M, Seiffert G, Keown K. Development of an infection-resistant vascular prosthesis. Arch Surg 1981; 116: 1403-07.
128 Morgan K, Clague RB, Shaw MJ, Holt PJL. Native type II collagen-induced arthritis in the rat. I. Incidence and humoral response to collagen. Ann Rheum Dis 1980; 39: 285-90.
129 Mosher DF, Proctor RA. Binding of factor XHIa mediated cross-linking of a 27 kilo-Dalton fragment of fibronectin to staphylococcus aureus. Science 1980; 209: 927-29.
130 Mosher DJ, Schad PE, Kleinman H. Cross-linking of fibronectin to collagen by blood coagulation factor XHIa. J Clin Invest 1979; 64: 781-87.
131 Mutschler W, Claes L, Kiefer H, Lob G, Mohr W. Die Gewebeverträglichkeit von Taurolin-Gel im Tierexperiment. In: Taurolin. Brückner WL, Pfirrmann RW. (eds). München: Urban & Schwarzenberg; 1985: 143-50.
132 Mutsumoto T. Tissue adhesives in surgery. Arch Surg 1968; 96: 226-30.
133 Nimni ME. Collagen. In: Collagen. Nimni E: CRC-Press; 1988
134 Olmo N, Lizarbe MA, Turnay J, Müller KP. Cell morphology, proliferation and collagen synthesis of human fibroblasts cultured on sepiolite-collagen complexes. J Bio Mat Res 1988; 22: 257-70.
135 Pachence JM, Berg RA, Silver FH. Collagen: its place in the medical device industry. Med Dev Diag Ind 1987; 01: 48-55.
136 Perez-Tamayo R. Degradation of collagen: pathology. In: Collagen in Health and Disease. Weiss JB, Jayson MIV. (eds). Edinburgh: Churchill Livingstone; 1982: 135-59.
137 Pharriss BB, Cooperman L. Role of collagen in polyarthritis questioned. Arthritis Rheum 1983; 26: 694-95.
138 Piez KA, Reddi AH. Extracellular Matrix Biochemistry. Amsterdam: Elsevier North Holland; 1984
139 Piez KA, Sporn MB. Transforming Growth Factor-ßs. In: Chemistry, Biology, and Therapeutics. Piez KA, Sporn MB. (eds). Ann NY Acad Sci 1990. Vol. 593.
140 Pitt CG, Schindler A. Biogradation of polymers. In: Controlled Drug Delivery Voll: Basic Concepts. Bruck StD. CRC-Press; 1983: 54-78.
141 Ponten B, Nordgaard JO. The use of collagen film (Cutyeol) as a dressing for donor areas in split skin grafting. Scand J Plast Surg 1976; 10: 237-40.
142 Postlethwaite AE, Seyer JM, Kang AH. Chemotactic attraction of human fibroblasts to type I, II and III collagens and collagen-derived peptides. Proc Natl Acad Sci USA 1978; 75: 871-75.
143 Rahn HD. Abdominoperineale Rektumamputation -Klinische Ergebnisse nach Anwendung von Sulmycin-Implant bei der Versorgung der präsakralen Wundhöhle. In: Kollagen als Wirkstoffträger. Stemberger A, Ascherl R, Lechner F, Blümel G. (Hrsg). Stuttgart, New York: Schattauer; 1989: 118-23.
144 Ramachandran GN, Ramakkrishnan C. Molecular structur. In: Biochemistry of Collagen. Ramachandran GN, Reddi AH. (eds). New York: Plenum Press; 1976: 45-84.
145 Reading EP. Cortical mastoidectomy. Lancet 1946; I: 811-12.
146 Reddi AH. Implant-stimulated interface reactions during collagenous bone matrixinduzed bone formation. J Biomed Mat Res 1985; 19: 233-39.
147 Reddi AH. Extracellular matrix and development. In: Extracellular Matrix Biochemistry. Piez KA, Reddi AH. (eds). Amsterdam: Elsevier North Holland; 1984: 375-412.
148 Redl H, Stanek G, Hischl A, Schlag G. Fibrinkleber-Antibiotika-Gemische - Festigkeit und Elutionsverhalten. In: Fibrinkleber in Orthopädie und Traumatologie. Cotta H, Braun H. (Hrsg). Stuttgart, New York: Thieme; 1982: 178-81.
149 Reigel MM, Hollier LH, Pairolero PC, Hallett JW. Early Experience with a New Collagen-impregnated Aortic Graft. Am Surg 1988; 54: 134-36.
150 Remberger K, Hübner G. Experimentelle Untersuchungen über Zell-und Gewebereaktionen nach Implantation von xenogenem Kollagenschaum. Res Exp Med (Berl) 1979; 175: 67-79.
151 Rich A, Crick FHC. The molecular structure of collagen. J Mol Biol 1961; 03: 483-506.
152 Robins SP. Turnover and cross-linking of collagen. In: Collagen in Health and Disease. Weiss JB, Jayson MIV. (eds). Edinburgh: Churchill Livingstone; 1982: 160-79.
153 Ronneberger H, Hein B. Untersuchungen mit einem Fibrin-Kleber an RattenhautStanzwunden. Arzneim Forsch/Drug Res 1984; 287-90.
154 Rubin K, Höök M. Substrate adhesion of rat hepatocytes. Mechanism of attachment to collagen substrates. Cell 1981; 24: 463-70.
155 Rueger JM, Wagner K, Konoid P, Pannike A. Biologische Wertigkeit von humaner Knochengelatine im Tier. In: Chirurgisches Forum ‘86 für experimentelle und klinische Forschung. Streicher HJ. (Hrsg). Berlin, Heidelberg: Springer; 1986: 23-26.
156 Sakakibara S, Inonye K, Shudo K, Kishida Y, Prockop DJ. Synthesis of (Pro-Hyp-Gly) of defined molecular weights. Evidence for the stabilization of collagen triple helix by hydroxyproline. Biochim Biophys Acta 1973; 303: 198-202.
157 Saldeen T. Vasoactive peptides derived from degradation of fibrinogen and fibrin. In: Molecular Biology of Fibrinogen and Fibrin. Mosesson MW, Doolittle RF. (eds). Ann NY Acad Sci. 1983. 408 424-37.
158 Santoro SA, Cunningham LW. Collagenmediated platelet aggregation: the role of multiple interactions between the platelet surface and collagen. Thromb Haemost 1980; 43: 158-62.
159 Schentag J, Cumbo Th, Jusko W, Plaut M. Gentamicin tissue accumulation and nephrotoxic reactions. JAMA 1978; 240: 2067-69.
160 Schentag J, Jusko W, Vance J. Gentamicin disposition and tissue accumulation on multiple dosing. J Pharmacokinet Biopharm 1977; 05: 559-77.
161 Schnell J, Plenio HG, Pauli W, Braun B, Korb G. The influence of ionizing radiation on various collagen-containing medical bioproducts. Radiosterilization of medical products. Int Atomic Energy, Vienna 1967; 145-61.
162 Schulitz KP, Winkelmann W. Die Retrospektive eines großen Patientenguts mit chronischer Osteomyelitis der Jahre 1930-1975. In: Hämatogene Osteomyelitis und posttraumatische Osteitis. Parsch K, Plaue R. (Hrsg). Uelzen: Med-Lit Verlags Ges; 1982: 231-37.
163 Shah PM, Vogel H. Bakterizide Aktivität von Gentamicin und Netilmicin unter Bedingungen, die die Serum-Pharmakokinetik simulieren. In: Aminoglykoside in der Behandlung schwerer Infektionen. Linzenmeier G. (Hrsg). Erlangen: perimed; 1981: 57-63.
164 Shimizu Y, Abe R, Teramatsu T. Studies on copolymers of collagen and a synthetic polymer. Biomat Med Dev Art Org 1977; 05: 49-66.
165 Shoshan S, Finkelstein S. Acceleration of wound healing induced by enriched collagen solutions. J Surg Res 1970; 10: 485-91.
166 Siegle RJ, McCoy JP, Schade W, Swanson NA. Intradermal implantation of bovine collagen. Arch Dermatol 1984; 120: 183-87.
167 Sixma JJ, Sakariassen KS, Stel HV, Houdijk WPM, In der Maur DW, Hamer RJ, De Groot PG, Van Mourik JA. Functional domains on von Willebrand factor. J Clin Invest 1984; 74: 736-44.
168 Speer DP, Chvapil M, Eskelson CD, Ulreich J. Biological effects of residual glutaraldehyde in glutaraldehyde-tanned collagen biomaterials. J Biomed Mat Res 1980; 14: 753-64.
169 Spilker G, Türk P, Stemberger A, Blümel G. Organerhaltende und gewebeschonende Möglichkeiten in der Leber-und Milzchirurgie - Experimentelle Untersuchungen. In: Fibrinklebung. Scheele J. (Hrsg). Berlin, Heidelberg, New York, Tokyo: Springer; 1984: 47-54.
170 Springorum HW, Adler CP, Jäger W, Ober E. Tierexperimentelle Untersuchung der Knochenregeneration am standardisierten Tibiadefekt des Kaninchens nach Implantation von Kollagenvlies im Vergleich zur autologen und homologen Spongiosaplastik. Z Orthop 1977; 115: 686-93.
171 Stemberger A, Blümel G. Fibrinogen-Fibrin conversion and inhibition of fibrinolysis. Thorac Cardiovasc Surg 1982; 30: 209-14.
172 Stemberger A, Fritsche HM, Primbs B, Blümel G. Fibrinogenkonzentrate und Kollagenschwämme zur Gewebeklebung. Med Welt 1978; 29: 720-24.
173 Stemberger A, Fritsche HM, Wriedt-Lübbe I, Haas S, Blümel G. Kollagen als Wundauflage und Hämostyptikum. In: Parenterale Ernährung in der Onkologie. Reissigl H. (Hrsg). Melsungen: Bibliomed; 1981: 127-34.
174 Stemberger A, Haas S, Tauber R, Blümel G. Das Prinzip der lokalen Blutstillung mit Fibrinkleber-Physiologie von Gerinnungskonzentraten in Kombination mit resorbierbaren kollagenen Wundauflagen. In: Lokale Blutstillung. Breddin HK, Siewert JR. (Hrsg). Melsungen: Bibliomed; 1982: 9-22.
175 Stemberger A, Hebeler W, Duspiva W, Blümel G. Fibrinogen cold-insoluble globulin mixtures as tissue adhesives. Thrombos Res 1978; 12: 907-10.
176 Stemberger A, Hörmann H. Dependence of staphylococcal clumping activity of fibrinogen on conformation. Thromb Res 1974; 04: 753-56.
177 Stemberger A, Sorg KH, Machka K, Blümel G. Technologische und biochemische Aspekte von Kollagen-Implantaten. In: Kollagen als Wirkstoffträger. Stemberger A, Ascherl R, Lechner F, Blümel G. (Hrsg). Stuttgart, New York: Schattauer; 1989: 17-29.
178 Stenzel KH, Miyata T, Rubin AL. Collagen as a biomaterial. Ann Rev Biophys 1974; 03: 231-53.
179 Struck H. Regulationsfunktionen des Kollagens während der Wundheilung. In: Wundheilung. Eckert P, Häring R. (Hrsg). Melsungen: Bibliomed; 1981: 15-23.
180 Struck H. Kollagenein biologischer Wundverband. Münch Med Wschr 1983; 125: 1111-13.
181 Sugarman B. Infections associated with often-used surgical materials. In: Infections Associated with Prosthetic Devices. Sugarman B, Young EJ. (eds). Boca-Raton/Florida: CRC-Press; 1984: 11-23.
182 Takeda U, Izawa M, Koeda T, Shibata U. Laboratory studies of collagen wound dressings (CAS). Part I: Experimental use on skin excisions and burns. J Dermatol 1983; 10: 475-86.
183 Tauber R, Stemberger A, Haas S, Wriedt-Lübbe I, Blümel G. Untersuchungen zur Versorgung des Nierenparenchyms mit Gewebekleber. Helv Chir Acta 1980; 47: 303-04.
184 Tencer AP, Mooney V, Brown KL, Silva PA. Compressive properties of polymer coated synthetic hydroxyapatite for bone grafting. J Biomed Mat Res 1985; 19: 957-69.
185 Thurer LR, Hauer JM. A comparison of preclotting techniques for prosthetic aortic replacement. Circulation 1982; 66 (Suppl I): 143-46.
186 Timpl R. Immunology of the collagens. In: Extracellular Matrix Biochemistry. Piez KA, Reddi AH. (eds). Amsterdam: Elsevier North Holland; 1984: 159-88.
187 Trelstad RL. Native collagen fractionation. In: Immunochemistry of the Extracellular Matrix, Voll: Methods. Furthmayer H. (ed). Boca-Raton/Florida: CRC-Press; 1982: 32-39.
188 Trentham DE, Townes AS, Kang AH. Humoral and cellular sensitivity to collagen in type II collagen-induced arthritis in rats. J Clin Invest 1978; 61: 89-96.
189 Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen: an experimental model of arthritis. J Exp Med 1977; 146: 857-68.
190 Ueno N, Refojo MF. Ocular pharmacology of drug release devices. In: Controlled Drug Delivery, Vol II: Clinical Applications. Bruck StD. Boca-Raton/Florida: CRC-Press; 1983: 90-101.
191 Urist MR, Huo YK, Brownell AG, Hohl WM, Buyske J. Purification of bovine bone morphogenetic protein by hydroxy apatite chromatography. Proc Natl Acad Sci USA 1984; 81: 371-75.
192 Urist MR, Liete A, Dawson E. Beta-Tricalciumphosphate delivery system for bone morphogenetic protein. Clin Orthop 1984; 187: 277-80.
193 Veis A. Bones and teeth. In: Extracellular Matrix Biochemistry. Pietz KA, Reddi AH. (eds). Amsterdam: Elsevier; 1984: 329-73.
194 Wahlig H, Dingeidein E. Gentamicinkonzentration in Körperflüssigkeiten von Patienten nach Implantation von Gentami-cin-PMMA-Kugeln. Sonderheft Unfallchirurgie, 8. Erlangen: VLE Verlag; 1977: 8-10.
195 Wahlig H, Dingeldein E. Collagen-Fleece for local treatment of infections, loaded with a new Gentamicin salt of low water solubility. The Third World Biomaterials Congress, Kyoto, Japan 1988; 231.
196 Wahlig H, Dingeldein E, Bergmann R, Reuss K. Experimentelle und pharmakokinetische Untersuchungen mit Gentami-cin-PMMA-Kugeln. Zbl Chirurgie 1979; 104: 923-33.
197 Waite JH, Tänzer ML. Polyphenolic substance of Mytilus edulis: novel adhesive containing L-Dopa and hydroxyproline. Science 1981; 212: 1038-40.
198 Weadock K, Silver FH, Wolff D. Diffusivity of 125-I-calmodulin through collagen membranes: effects of source concentration and membrane swelling ratio. Biomaterials 1986; 07: 263-67.
199 Weiss JB, Ayad S. An introduction to collagen. In: Collagen in Health and Disease. Weiss JB, Jayson MIV. (eds). Edinburgh: Churchill Livingstone; 1982
200 Weiss JB, Jayson MIV. Collagen in Health and Disease. Edinburgh: Churchill Livingstone; 1982
201 Werb Z. Degradation of collagen: mechanisms. In: Collagen in Health and Disease. Weiss JB, Jayson MIV. (eds). Edinburgh: Churchill Livingstone; 1982: 121-35.
202 Wolley DE. Mammalian collagenases. In: Extracellular Matrix Biochemistry. Piez KA, Reddi AH. (eds). Amsterdam: Elsevier North Holland; 1984: 119-59.
203 Yamada KM. Cell surface interactions with extracellular materials. Ann Rev Biochem 1983; 52: 761-99.
204 Yannas IV, Tobolsky AV. Cross-linking of gelatine by dehydration. Nature 1967; 215: 509-10.
205 Yates HG, Barros D'Sa. The preclotting of porous arterial prostheses. Ann Surg 1978; 188: 611-22.